Abstract: The present discloses relates to a composition, a kit or a method using an eIF4E inhibitor for diagnosis or treatment of a condition associated with increased activity of eIF4E.
Type:
Grant
Filed:
September 3, 2020
Date of Patent:
March 10, 2026
Assignee:
SOVARGEN CO., LTD.
Inventors:
Jeong Ho Lee, Jang Keun Kim, Byung Tae Kim, Sun-Gyun Kim
© 2026 Justia
